Global Artesunate Tablet Market Intelligence Brief (2026–2036)
Market Overview
Western Market Research projects that the Global Artesunate Tablet Market was valued at USD xxxx million in 2025 and is expected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Artesunate, a derivative of artemisinin, is widely used as an antimalarial drug, often in combination therapies. Rising prevalence of malaria in tropical regions, increasing government initiatives for malaria eradication, and expanding access to affordable antimalarial drugs are key growth drivers.
The study integrates primary and secondary research, covering government regulations, competitive dynamics, technological innovations, and evolving patient preferences.
Impact of COVID-19
- Supply chain disruptions in 2020 affected drug availability in malaria-endemic regions.
- Shift in healthcare priorities toward COVID-19 temporarily slowed malaria control programs.
- Post-pandemic recovery renewed focus on malaria eradication, boosting demand for artesunate tablets.
Market Segmentation
By Type
- Monoaromatic Artesunate
- Compound Artesunate (artesunate combined with amodiaquine, mefloquine, or other antimalarials)
- Fixed-Dose Combination Tablets (additional segmentation)
By Application
- Hospitals
- Clinics
- Community Health Centers
- Others (NGO programs, government distribution schemes)
By Distribution Channel (additional segmentation)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Public Health Programs
By End-User (additional segmentation)
- Adults
- Children
- Pregnant Women (restricted use under medical supervision)
Regional Analysis
- North America: Limited demand; focus on imported cases of malaria and research applications.
- Europe: Moderate demand; primarily for travelers and imported malaria cases.
- Asia-Pacific: Largest market; high malaria prevalence in India, Southeast Asia, and parts of China.
- South America: Significant demand in Brazil and Amazon basin regions.
- Middle East & Africa: Fastest-growing market; high malaria burden, strong government and NGO-driven demand.
Key Players
- Fosun Pharma (Guilin)
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- Acino
- MCW Healthcare
- Additional Players:
- Novartis AG
- Strides Pharma Science
- Torrent Pharmaceuticals
- Ranbaxy Laboratories (Sun Pharma)
- Hetero Drugs
- Glenmark Pharmaceuticals
- Medopharm
- Alkem Laboratories
Porter’s Five Forces Analysis
- Threat of New Entrants – Moderate; regulatory approvals required but demand is strong in endemic regions.
- Bargaining Power of Suppliers – Moderate; raw material (artemisinin) supply concentrated in specific geographies.
- Bargaining Power of Buyers – High; governments and NGOs purchase in bulk, demanding cost-effective solutions.
- Threat of Substitutes – Moderate; other artemisinin-based combination therapies (ACTs) compete.
- Industry Rivalry – High; multiple generics and branded formulations compete in malaria-endemic regions.
SWOT Analysis
Strengths
- Proven efficacy in malaria treatment.
- Strong demand in endemic regions.
- Wide availability of generic formulations.
Weaknesses
- Risk of resistance development.
- Limited demand in non-endemic regions.
- Dependence on artemisinin supply chains.
Opportunities
- Expansion in Africa and Southeast Asia.
- Development of fixed-dose combinations for better compliance.
- Partnerships with NGOs and government health programs.
Threats
- Emergence of drug-resistant malaria strains.
- Stringent regulatory requirements.
- Competition from alternative ACTs.
Trend Analysis
- Combination therapies: Increasing use of artesunate with other antimalarials to prevent resistance.
- Public health initiatives: WHO and government programs driving large-scale distribution.
- Digital health integration: Mobile health platforms supporting malaria treatment adherence.
- Research focus: Development of next-generation artemisinin derivatives.
Drivers & Challenges
Drivers
- Rising prevalence of malaria in tropical regions.
- Strong government and NGO support for malaria eradication.
- Expanding healthcare infrastructure in emerging markets.
- Increasing awareness and accessibility of ACTs.
Challenges
- Risk of artemisinin resistance.
- Supply chain vulnerabilities for raw materials.
- Price sensitivity in developing regions.
- Regulatory hurdles in drug approvals.
Value Chain Analysis
- Raw Material Suppliers – Artemisinin derived from Artemisia annua plants.
- Manufacturers – Formulation of artesunate tablets and ACT combinations.
- Distributors – Hospital pharmacies, retail chains, online platforms, NGO programs.
- Consumers – Patients in malaria-endemic regions.
- Regulators – WHO, FDA, EMA, and regional authorities ensuring safety and compliance.
Quick Recommendations for Stakeholders
- Manufacturers: Focus on fixed-dose combinations and resistance management strategies.
- Distributors: Strengthen partnerships with NGOs and government programs for bulk distribution.
- Regulators: Support faster approvals for ACTs to combat resistance.
- Investors: Target Africa and Southeast Asia for high-growth opportunities.
- Healthcare Providers: Educate communities on adherence and resistance prevention.
Explore more reports here-
https://westernmarketresearch.com/reports
1. Market Overview of Artesunate Tablet
1.1 Artesunate Tablet Market Overview
1.1.1 Artesunate Tablet Product Scope
1.1.2 Market Status and Outlook
1.2 Artesunate Tablet Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Artesunate Tablet Historic Market Size by Regions
1.4 Artesunate Tablet Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Artesunate Tablet Sales Market by Type
2.1 Global Artesunate Tablet Historic Market Size by Type
2.2 Global Artesunate Tablet Forecasted Market Size by Type
2.3 Monoaromatic Artesunate
2.4 Compound Artesunate
3. Covid-19 Impact Artesunate Tablet Sales Market by Application
3.1 Global Artesunate Tablet Historic Market Size by Application
3.2 Global Artesunate Tablet Forecasted Market Size by Application
3.3 Hospital
3.4 Clinic
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Artesunate Tablet Production Capacity Market Share by Manufacturers
4.2 Global Artesunate Tablet Revenue Market Share by Manufacturers
4.3 Global Artesunate Tablet Average Price by Manufacturers
5. Company Profiles and Key Figures in Artesunate Tablet Business
5.1 Fosun Pharma (Guilin)
5.1.1 Fosun Pharma (Guilin) Company Profile
5.1.2 Fosun Pharma (Guilin) Artesunate Tablet Product Specification
5.1.3 Fosun Pharma (Guilin) Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.2 Ipca Laboratories
5.2.1 Ipca Laboratories Company Profile
5.2.2 Ipca Laboratories Artesunate Tablet Product Specification
5.2.3 Ipca Laboratories Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.3 Sanofi Aventis
5.3.1 Sanofi Aventis Company Profile
5.3.2 Sanofi Aventis Artesunate Tablet Product Specification
5.3.3 Sanofi Aventis Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.4 Ajanta Pharma
5.4.1 Ajanta Pharma Company Profile
5.4.2 Ajanta Pharma Artesunate Tablet Product Specification
5.4.3 Ajanta Pharma Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.5 Shin Poong
5.5.1 Shin Poong Company Profile
5.5.2 Shin Poong Artesunate Tablet Product Specification
5.5.3 Shin Poong Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.6 Cipla
5.6.1 Cipla Company Profile
5.6.2 Cipla Artesunate Tablet Product Specification
5.6.3 Cipla Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.7 Acino
5.7.1 Acino Company Profile
5.7.2 Acino Artesunate Tablet Product Specification
5.7.3 Acino Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
5.8 MCW Healthcare
5.8.1 MCW Healthcare Company Profile
5.8.2 MCW Healthcare Artesunate Tablet Product Specification
5.8.3 MCW Healthcare Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Artesunate Tablet Market Size
6.2 North America Artesunate Tablet Key Players in North America
6.3 North America Artesunate Tablet Market Size by Type
6.4 North America Artesunate Tablet Market Size by Application
7. East Asia
7.1 East Asia Artesunate Tablet Market Size
7.2 East Asia Artesunate Tablet Key Players in North America
7.3 East Asia Artesunate Tablet Market Size by Type
7.4 East Asia Artesunate Tablet Market Size by Application
8. Europe
8.1 Europe Artesunate Tablet Market Size
8.2 Europe Artesunate Tablet Key Players in North America
8.3 Europe Artesunate Tablet Market Size by Type
8.4 Europe Artesunate Tablet Market Size by Application
9. South Asia
9.1 South Asia Artesunate Tablet Market Size
9.2 South Asia Artesunate Tablet Key Players in North America
9.3 South Asia Artesunate Tablet Market Size by Type
9.4 South Asia Artesunate Tablet Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Artesunate Tablet Market Size
10.2 Southeast Asia Artesunate Tablet Key Players in North America
10.3 Southeast Asia Artesunate Tablet Market Size by Type
10.4 Southeast Asia Artesunate Tablet Market Size by Application
11. Middle East
11.1 Middle East Artesunate Tablet Market Size
11.2 Middle East Artesunate Tablet Key Players in North America
11.3 Middle East Artesunate Tablet Market Size by Type
11.4 Middle East Artesunate Tablet Market Size by Application
12. Africa
12.1 Africa Artesunate Tablet Market Size
12.2 Africa Artesunate Tablet Key Players in North America
12.3 Africa Artesunate Tablet Market Size by Type
12.4 Africa Artesunate Tablet Market Size by Application
13. Oceania
13.1 Oceania Artesunate Tablet Market Size
13.2 Oceania Artesunate Tablet Key Players in North America
13.3 Oceania Artesunate Tablet Market Size by Type
13.4 Oceania Artesunate Tablet Market Size by Application
14. South America
14.1 South America Artesunate Tablet Market Size
14.2 South America Artesunate Tablet Key Players in North America
14.3 South America Artesunate Tablet Market Size by Type
14.4 South America Artesunate Tablet Market Size by Application
15. Rest of the World
15.1 Rest of the World Artesunate Tablet Market Size
15.2 Rest of the World Artesunate Tablet Key Players in North America
15.3 Rest of the World Artesunate Tablet Market Size by Type
15.4 Rest of the World Artesunate Tablet Market Size by Application
16 Artesunate Tablet Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Market Segmentation
By Type
- Monoaromatic Artesunate
- Compound Artesunate (artesunate combined with amodiaquine, mefloquine, or other antimalarials)
- Fixed-Dose Combination Tablets (additional segmentation)
By Application
- Hospitals
- Clinics
- Community Health Centers
- Others (NGO programs, government distribution schemes)
By Distribution Channel (additional segmentation)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Public Health Programs
By End-User (additional segmentation)
- Adults
- Children
- Pregnant Women (restricted use under medical supervision)
Regional Analysis
- North America: Limited demand; focus on imported cases of malaria and research applications.
- Europe: Moderate demand; primarily for travelers and imported malaria cases.
- Asia-Pacific: Largest market; high malaria prevalence in India, Southeast Asia, and parts of China.
- South America: Significant demand in Brazil and Amazon basin regions.
- Middle East & Africa: Fastest-growing market; high malaria burden, strong government and NGO-driven demand.
Key Players
- Fosun Pharma (Guilin)
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- Acino
- MCW Healthcare
